Z

Zomedica Corp
AMEX:ZOM

Watchlist Manager
Zomedica Corp
AMEX:ZOM
Watchlist
Price: 0.1235 USD 2.92%
Market Cap: 121m USD
Have any thoughts about
Zomedica Corp?
Write Note

Gross Margin
Zomedica Corp

69.6%
Current
64%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
69.6%
=
Gross Profit
18.6m
/
Revenue
26.7m

Gross Margin Across Competitors

Country US
Market Cap 117.6m USD
Gross Margin
70%
Country US
Market Cap 199.5B USD
Gross Margin
56%
Country US
Market Cap 190.6B USD
Gross Margin
67%
Country US
Market Cap 140.3B USD
Gross Margin
64%
Country US
Market Cap 133.7B USD
Gross Margin
69%
Country IE
Market Cap 104.5B USD
Gross Margin
65%
Country US
Market Cap 65.8B USD
Gross Margin
45%
Country DE
Market Cap 58.1B EUR
Gross Margin
38%
Country US
Market Cap 44.3B USD
Gross Margin
79%
Country CN
Market Cap 308.3B CNY
Gross Margin
64%
Country US
Market Cap 36.4B USD
Gross Margin
41%
No Stocks Found

Zomedica Corp
Glance View

Market Cap
121m USD
Industry
Health Care

Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The company is headquartered in Ann Arbor, Michigan and currently employs 85 full-time employees. The company went IPO on 2013-10-28. The firm is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The firm's Diagnostics segment consists of TRUFORMA products. Its Therapeutics segment consists of PulseVet and Assisi products. Its TRUFORMA Bulk Acoustic Wave (BAW) point-of-care diagnostic platform is marketed with full diagnostic and thyroid panels for dogs and cats that include the only assays of these types available at the point of care to test for feline optimized TSH, endogenous ACTH, Free T4, and quantitative cortisol, along with a total T4 assay. The VetGuardian is its zero-touch vital signs remote monitoring system that enables contact-free, continuous monitoring of a pet's vital signs. The PulseVet is its electrohydraulic shockwave therapy platform. Its Assisi Loop line of products treats pain and inflammation through the delivery of targeted pulsed electromagnetic field focused energy (tPEMF).

ZOM Intrinsic Value
0.1314 USD
Undervaluation 6%
Intrinsic Value
Price
Z

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
69.6%
=
Gross Profit
18.6m
/
Revenue
26.7m
What is the Gross Margin of Zomedica Corp?

Based on Zomedica Corp's most recent financial statements, the company has Gross Margin of 69.6%.